NEW YORK (GenomeWeb) — Although Alere launched the Alere i molecular diagnostic platform and influenza assay only three months ago, the company announced this week that a three-year contract worth up to $12.9 million from the US Department of Health and Human Services' Biomedical Advanced Researc
NEW YORK (GenomeWeb) — This week, Waltham, Mass.-headquartered medical diagnostics company Alere received FDA clearance for a new influenza test that can both detect and discriminate nucleic acids of influenza A and influenza B viruses.
NEW YORK (GenomeWeb) — Researchers at The Royal Tropical Institute in Amsterdam have developed a novel isothermal recombinase polymerase amplification assay for pathogenic Leptospira, the spirochete bacterium that causes leptospirosis.
A team at the University of Potsdam and the Fraunhofer Institute for Biomedical Engineering (IBMT) in Germany has developed a lateral flow assay to detect P. falciparum parasite, the most deadly of the four Plasmodium species that cause malaria.
Alere President and CEO Ron Zwanziger last week provided investors with an update on the development timeline for a pair of point-of-care nucleic acid testing plartforms, the company's first molecular diagnostics products.